XML 106 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Cash and cash equivalents The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
 
December 31,
 
2019
 
2018
 
2017
 
(In millions)
Cash and cash equivalents
$
2,452

 
$
2,826

 
$
3,186

Restricted cash and cash equivalents, non-current
56

 
100

 
95

Restricted cash and cash equivalents, current

 

 
9

Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$
2,508

 
$
2,926

 
$
3,290


Restricted cash and cash equivalents The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
 
December 31,
 
2019
 
2018
 
2017
 
(In millions)
Cash and cash equivalents
$
2,452

 
$
2,826

 
$
3,186

Restricted cash and cash equivalents, non-current
56

 
100

 
95

Restricted cash and cash equivalents, current

 

 
9

Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$
2,508

 
$
2,926

 
$
3,290


Summarized premium revenue
The following table summarizes premium revenue by health plan for the periods presented:
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
(Dollars in millions)
California
$
2,266

 
14.0
%
 
$
2,150

 
12.2
%
 
$
2,701

 
14.3
%
Florida
734

 
4.5

 
1,790

 
10.2

 
2,568

 
13.6

Illinois
1,002

 
6.2

 
793

 
4.5

 
593

 
3.1

Michigan
1,624

 
10.0

 
1,601

 
9.1

 
1,596

 
8.5

New Mexico (1)

 

 
1,356

 
7.7

 
1,368

 
7.3

Ohio
2,553

 
15.8

 
2,388

 
13.6

 
2,216

 
11.8

Puerto Rico
474

 
2.9

 
696

 
3.9

 
732

 
3.9

South Carolina
583

 
3.6

 
495

 
2.8

 
445

 
2.4

Texas
2,991

 
18.5

 
3,244

 
18.4

 
2,813

 
14.9

Washington
2,695

 
16.6

 
2,361

 
13.4

 
2,608

 
13.8

Other (1)
1,286

 
7.9

 
738

 
4.2

 
1,214

 
6.4

Total
$
16,208

 
100.0
%
 
$
17,612

 
100.0
%
 
$
18,854

 
100.0
%

_______________________
(1)
“Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to our consolidated operating results. In 2019, “Other” also includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its results are not individually significant to our consolidated operating results in 2019.
Amounts due to government agencies
A summary of the categories of amounts due government agencies is as follows:
 
December 31,
 
2019
 
2018
 
(In millions)
Medicaid program:
 
 
 
Medical cost floors and corridors
$
74

 
$
103

Other amounts due to states
84

 
81

Marketplace program:
 
 
 
Risk adjustment
368

 
466

Cost sharing reduction

 
183

Other
138

 
134

Total
$
664

 
$
967


Quality incentive premium revenue recognized
The following table quantifies the quality incentive premium revenue recognized for the periods presented, including the amounts earned in the periods presented and prior periods.
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
(In millions)
Maximum available quality incentive premium - current period
$
186

 
$
182

 
$
150

 
 
 
 
 
 
Amount of quality incentive premium revenue recognized in current period:
 
 
 
 
 
Earned current period
$
156

 
$
133

 
$
97

Earned prior periods
38

 
31

 
10

Total
$
194

 
$
164

 
$
107

 
 
 
 
 
 
Quality incentive premium revenue recognized as a percentage of total premium revenue
1.2
%
 
0.9
%
 
0.6
%